1	Mitogen-activated	_	JJ	_	_	4	NMOD	_	_
2	protein	_	NN	_	_	4	NMOD	_	_
3	kinase	_	NN	_	_	4	NMOD	_	_
4	kinase	_	NN	_	_	5	NMOD	_	_
5	signaling	_	NN	_	_	6	VMOD	_	_
6	promotes	_	VBZ	_	_	0	ROOT	_	_
7	growth	_	NN	_	_	6	VMOD	_	_
8	and	_	CC	_	_	7	COORD	_	_
9	vascularization	_	NN	_	_	8	CONJ	_	_
10	of	_	IN	_	_	7	NMOD	_	_
11	fibrosarcoma	_	NN	_	_	10	PMOD	_	_
12	.	_	.	_	_	6	P	_	_
		
1	We	_	PRP	_	_	2	VMOD	_	_
2	hypothesized	_	VBD	_	_	0	ROOT	_	_
3	that	_	IN	_	_	2	VMOD	_	_
4	signaling	_	NN	_	_	18	VMOD	_	_
5	through	_	IN	_	_	4	NMOD	_	_
6	multiple	_	JJ	_	_	17	NMOD	_	_
7	mitogen-activated	_	JJ	_	_	13	NMOD	_	_
8	protein	_	NN	_	_	13	NMOD	_	_
9	kinase	_	NN	_	_	13	NMOD	_	_
10	(	_	(	_	_	13	P	_	_
11	MAPK	_	NN	_	_	13	NMOD	_	_
12	)	_	)	_	_	13	P	_	_
13	kinase	_	NN	_	_	17	NMOD	_	_
14	(	_	(	_	_	15	P	_	_
15	MKK	_	NN	_	_	13	PRN	_	_
16	)	_	)	_	_	15	P	_	_
17	pathways	_	NNS	_	_	5	PMOD	_	_
18	is	_	VBZ	_	_	3	SUB	_	_
19	essential	_	JJ	_	_	18	VMOD	_	_
20	for	_	IN	_	_	19	AMOD	_	_
21	the	_	DT	_	_	22	NMOD	_	_
22	growth	_	NN	_	_	20	PMOD	_	_
23	and	_	CC	_	_	22	COORD	_	_
24	vascularization	_	NN	_	_	23	CONJ	_	_
25	of	_	IN	_	_	22	NMOD	_	_
26	soft-tissue	_	JJ	_	_	27	NMOD	_	_
27	sarcomas	_	NNS	_	_	25	PMOD	_	_
28	,	_	,	_	_	27	P	_	_
29	which	_	WDT	_	_	30	VMOD	_	_
30	are	_	VBP	_	_	27	NMOD	_	_
31	malignant	_	JJ	_	_	32	NMOD	_	_
32	tumors	_	NNS	_	_	30	VMOD	_	_
33	derived	_	VBN	_	_	32	APPO	_	_
34	from	_	IN	_	_	33	VMOD	_	_
35	mesenchymal	_	JJ	_	_	36	NMOD	_	_
36	tissues	_	NNS	_	_	34	PMOD	_	_
37	.	_	.	_	_	2	P	_	_
		
1	We	_	PRP	_	_	2	VMOD	_	_
2	tested	_	VBD	_	_	0	ROOT	_	_
3	this	_	DT	_	_	2	VMOD	_	_
4	using	_	VBG	_	_	2	VMOD	_	_
5	HT-1080	_	NN	_	_	4	VMOD	_	_
6	,	_	,	_	_	5	P	_	_
7	NCI	_	NN	_	_	5	COORD	_	_
8	,	_	,	_	_	7	P	_	_
9	and	_	CC	_	_	7	COORD	_	_
10	Shac	_	NN	_	_	13	NMOD	_	_
11	fibrosarcoma-derived	_	JJ	_	_	13	NMOD	_	_
12	cell	_	NN	_	_	13	NMOD	_	_
13	lines	_	NNS	_	_	9	CONJ	_	_
14	and	_	CC	_	_	13	COORD	_	_
15	anthrax	_	NN	_	_	17	NMOD	_	_
16	lethal	_	JJ	_	_	17	NMOD	_	_
17	toxin	_	NN	_	_	14	CONJ	_	_
18	(	_	(	_	_	19	P	_	_
19	LeTx	_	NN	_	_	17	PRN	_	_
20	)	_	)	_	_	19	P	_	_
21	,	_	,	_	_	17	P	_	_
22	a	_	DT	_	_	24	NMOD	_	_
23	bacterial	_	JJ	_	_	24	NMOD	_	_
24	toxin	_	NN	_	_	17	APPO	_	_
25	that	_	WDT	_	_	26	VMOD	_	_
26	inactivates	_	VBZ	_	_	24	NMOD	_	_
27	MKKs	_	NNS	_	_	26	VMOD	_	_
28	.	_	.	_	_	2	P	_	_
		
1	Western	_	NN	_	_	2	NMOD	_	_
2	blots	_	NNS	_	_	3	VMOD	_	_
3	confirmed	_	VBD	_	_	0	ROOT	_	_
4	that	_	IN	_	_	3	VMOD	_	_
5	LeTx	_	NN	_	_	6	NMOD	_	_
6	treatment	_	NN	_	_	7	VMOD	_	_
7	reduced	_	VBD	_	_	4	SUB	_	_
8	the	_	DT	_	_	9	NMOD	_	_
9	levels	_	NNS	_	_	7	VMOD	_	_
10	of	_	IN	_	_	9	NMOD	_	_
11	phosphorylated	_	VBN	_	_	14	NMOD	_	_
12	extracellular	_	JJ	_	_	14	NMOD	_	_
13	signal-regulated	_	JJ	_	_	14	NMOD	_	_
14	kinase	_	NN	_	_	10	PMOD	_	_
15	and	_	CC	_	_	14	COORD	_	_
16	p38	_	NN	_	_	17	NMOD	_	_
17	MAPK	_	NN	_	_	15	CONJ	_	_
18	in	_	FW	_	_	7	VMOD	_	_
19	vitro	_	FW	_	_	18	AMOD	_	_
20	.	_	.	_	_	3	P	_	_
		
1	Although	_	IN	_	_	15	VMOD	_	_
2	short	_	JJ	_	_	3	NMOD	_	_
3	treatments	_	NNS	_	_	8	VMOD	_	_
4	with	_	IN	_	_	3	NMOD	_	_
5	LeTx	_	NN	_	_	4	PMOD	_	_
6	only	_	RB	_	_	8	VMOD	_	_
7	modestly	_	RB	_	_	6	AMOD	_	_
8	affected	_	VBD	_	_	1	SUB	_	_
9	cell	_	NN	_	_	10	NMOD	_	_
10	proliferation	_	NN	_	_	8	VMOD	_	_
11	,	_	,	_	_	15	P	_	_
12	sustained	_	JJ	_	_	13	NMOD	_	_
13	treatment	_	NN	_	_	15	VMOD	_	_
14	markedly	_	RB	_	_	15	VMOD	_	_
15	reduced	_	VBD	_	_	0	ROOT	_	_
16	cell	_	NN	_	_	17	NMOD	_	_
17	numbers	_	NNS	_	_	15	VMOD	_	_
18	.	_	.	_	_	15	P	_	_
		
1	LeTx	_	NN	_	_	4	VMOD	_	_
2	also	_	RB	_	_	4	VMOD	_	_
3	substantially	_	RB	_	_	4	VMOD	_	_
4	inhibited	_	VBD	_	_	0	ROOT	_	_
5	the	_	DT	_	_	7	NMOD	_	_
6	extracellular	_	JJ	_	_	7	NMOD	_	_
7	release	_	NN	_	_	4	VMOD	_	_
8	of	_	IN	_	_	7	NMOD	_	_
9	angioproliferative	_	JJ	_	_	10	NMOD	_	_
10	factors	_	NNS	_	_	8	PMOD	_	_
11	including	_	VBG	_	_	10	NMOD	_	_
12	vascular	_	JJ	_	_	15	NMOD	_	_
13	endothelial	_	JJ	_	_	15	NMOD	_	_
14	growth	_	NN	_	_	15	NMOD	_	_
15	factor	_	NN	_	_	11	PMOD	_	_
16	,	_	,	_	_	15	P	_	_
17	interleukin-8	_	NN	_	_	15	COORD	_	_
18	,	_	,	_	_	17	P	_	_
19	and	_	CC	_	_	17	COORD	_	_
20	basic	_	JJ	_	_	23	NMOD	_	_
21	fibroblast	_	NN	_	_	23	NMOD	_	_
22	growth	_	NN	_	_	23	NMOD	_	_
23	factor	_	NN	_	_	19	CONJ	_	_
24	.	_	.	_	_	4	P	_	_
		
1	Similar	_	JJ	_	_	2	NMOD	_	_
2	results	_	NNS	_	_	3	VMOD	_	_
3	were	_	VBD	_	_	0	ROOT	_	_
4	obtained	_	VBN	_	_	3	VC	_	_
5	with	_	IN	_	_	4	VMOD	_	_
6	cell	_	NN	_	_	7	NMOD	_	_
7	lines	_	NNS	_	_	5	PMOD	_	_
8	derived	_	VBN	_	_	7	APPO	_	_
9	from	_	IN	_	_	8	VMOD	_	_
10	malignant	_	JJ	_	_	12	NMOD	_	_
11	fibrous	_	JJ	_	_	12	NMOD	_	_
12	histiocytomas	_	NNS	_	_	9	PMOD	_	_
13	,	_	,	_	_	12	P	_	_
14	leiomyosarcomas	_	NNS	_	_	12	COORD	_	_
15	,	_	,	_	_	14	P	_	_
16	and	_	CC	_	_	14	COORD	_	_
17	liposarcomas	_	NNS	_	_	16	CONJ	_	_
18	.	_	.	_	_	3	P	_	_
		
1	In	_	IN	_	_	5	VMOD	_	_
2	vivo	_	FW	_	_	1	PMOD	_	_
3	,	_	,	_	_	5	P	_	_
4	LeTx	_	NN	_	_	5	VMOD	_	_
5	decreased	_	VBD	_	_	0	ROOT	_	_
6	MAPK	_	NN	_	_	7	NMOD	_	_
7	activity	_	NN	_	_	5	VMOD	_	_
8	and	_	CC	_	_	5	COORD	_	_
9	blocked	_	VBD	_	_	8	CONJ	_	_
10	fibrosarcoma	_	NN	_	_	11	NMOD	_	_
11	growth	_	NN	_	_	9	VMOD	_	_
12	.	_	.	_	_	5	P	_	_
		
1	Growth	_	NN	_	_	2	NMOD	_	_
2	inhibition	_	NN	_	_	3	VMOD	_	_
3	correlated	_	VBD	_	_	0	ROOT	_	_
4	with	_	IN	_	_	3	VMOD	_	_
5	decreased	_	VBN	_	_	7	NMOD	_	_
6	cellular	_	JJ	_	_	7	NMOD	_	_
7	proliferation	_	NN	_	_	4	PMOD	_	_
8	and	_	CC	_	_	7	COORD	_	_
9	extensive	_	JJ	_	_	10	NMOD	_	_
10	necrosis	_	NN	_	_	8	CONJ	_	_
11	,	_	,	_	_	3	P	_	_
12	and	_	CC	_	_	3	COORD	_	_
13	it	_	PRP	_	_	14	VMOD	_	_
14	was	_	VBD	_	_	12	CONJ	_	_
15	accompanied	_	VBN	_	_	14	VC	_	_
16	by	_	IN	_	_	15	VMOD	_	_
17	a	_	DT	_	_	18	NMOD	_	_
18	decrease	_	NN	_	_	16	PMOD	_	_
19	in	_	IN	_	_	18	NMOD	_	_
20	tumor	_	NN	_	_	23	NMOD	_	_
21	mean	_	NN	_	_	23	NMOD	_	_
22	vessel	_	NN	_	_	23	NMOD	_	_
23	density	_	NN	_	_	19	PMOD	_	_
24	as	_	RB	_	_	23	COORD	_	_
25	well	_	RB	_	_	24	DEP	_	_
26	as	_	IN	_	_	24	DEP	_	_
27	a	_	DT	_	_	28	NMOD	_	_
28	reduction	_	NN	_	_	24	CONJ	_	_
29	in	_	IN	_	_	28	NMOD	_	_
30	serum	_	NN	_	_	31	NMOD	_	_
31	expression	_	NN	_	_	29	PMOD	_	_
32	of	_	IN	_	_	31	NMOD	_	_
33	angioproliferative	_	JJ	_	_	34	NMOD	_	_
34	cytokines	_	NNS	_	_	32	PMOD	_	_
35	.	_	.	_	_	3	P	_	_
		
1	Vital	_	JJ	_	_	2	NMOD	_	_
2	imaging	_	NN	_	_	10	VMOD	_	_
3	using	_	VBG	_	_	2	APPO	_	_
4	high-resolution	_	JJ	_	_	5	NMOD	_	_
5	ultrasound	_	NN	_	_	3	VMOD	_	_
6	enhanced	_	VBN	_	_	5	APPO	_	_
7	with	_	IN	_	_	6	VMOD	_	_
8	contrast	_	NN	_	_	9	NMOD	_	_
9	microbubbles	_	NNS	_	_	7	PMOD	_	_
10	revealed	_	VBD	_	_	0	ROOT	_	_
11	that	_	IN	_	_	10	VMOD	_	_
12	the	_	DT	_	_	13	NMOD	_	_
13	effects	_	NNS	_	_	19	VMOD	_	_
14	of	_	IN	_	_	13	NMOD	_	_
15	LeTx	_	NN	_	_	14	PMOD	_	_
16	on	_	IN	_	_	13	NMOD	_	_
17	tumor	_	NN	_	_	18	NMOD	_	_
18	perfusion	_	NN	_	_	16	PMOD	_	_
19	were	_	VBD	_	_	11	SUB	_	_
20	remarkably	_	RB	_	_	21	AMOD	_	_
21	rapid	_	JJ	_	_	19	VMOD	_	_
22	(	_	(	_	_	26	P	_	_
23	less	_	JJR	_	_	25	DEP	_	_
24	than	_	IN	_	_	25	DEP	_	_
25	24	_	CD	_	_	26	NMOD	_	_
26	h	_	NN	_	_	21	PRN	_	_
27	)	_	)	_	_	26	P	_	_
28	and	_	CC	_	_	19	COORD	_	_
29	resulted	_	VBD	_	_	28	CONJ	_	_
30	in	_	IN	_	_	29	VMOD	_	_
31	a	_	DT	_	_	33	NMOD	_	_
32	marked	_	JJ	_	_	33	NMOD	_	_
33	reduction	_	NN	_	_	30	PMOD	_	_
34	of	_	IN	_	_	33	NMOD	_	_
35	perfusion	_	NN	_	_	34	PMOD	_	_
36	within	_	IN	_	_	33	NMOD	_	_
37	the	_	DT	_	_	38	NMOD	_	_
38	tumor	_	NN	_	_	36	PMOD	_	_
39	but	_	CC	_	_	30	COORD	_	_
40	not	_	RB	_	_	41	DEP	_	_
41	in	_	IN	_	_	39	CONJ	_	_
42	nontumor	_	NN	_	_	43	NMOD	_	_
43	tissues	_	NNS	_	_	41	PMOD	_	_
44	.	_	.	_	_	10	P	_	_
		
1	These	_	DT	_	_	2	NMOD	_	_
2	results	_	NNS	_	_	3	VMOD	_	_
3	are	_	VBP	_	_	0	ROOT	_	_
4	consistent	_	JJ	_	_	3	VMOD	_	_
5	with	_	IN	_	_	4	AMOD	_	_
6	our	_	PRP$	_	_	8	NMOD	_	_
7	initial	_	JJ	_	_	8	NMOD	_	_
8	hypothesis	_	NN	_	_	5	PMOD	_	_
9	and	_	CC	_	_	3	COORD	_	_
10	lead	_	VBP	_	_	9	CONJ	_	_
11	us	_	PRP	_	_	12	VMOD	_	_
12	to	_	TO	_	_	10	VMOD	_	_
13	propose	_	VB	_	_	12	IM	_	_
14	that	_	IN	_	_	13	VMOD	_	_
15	MKK	_	NN	_	_	16	NMOD	_	_
16	inhibition	_	NN	_	_	19	VMOD	_	_
17	by	_	IN	_	_	16	NMOD	_	_
18	LeTx	_	NN	_	_	17	PMOD	_	_
19	is	_	VBZ	_	_	14	SUB	_	_
20	a	_	DT	_	_	23	NMOD	_	_
21	broadly	_	RB	_	_	22	AMOD	_	_
22	effective	_	JJ	_	_	23	NMOD	_	_
23	strategy	_	NN	_	_	19	VMOD	_	_
24	for	_	IN	_	_	23	NMOD	_	_
25	targeting	_	VBG	_	_	24	PMOD	_	_
26	neovascularization	_	NN	_	_	25	VMOD	_	_
27	in	_	IN	_	_	26	NMOD	_	_
28	fibrosarcomas	_	NNS	_	_	27	PMOD	_	_
29	and	_	CC	_	_	28	COORD	_	_
30	other	_	JJ	_	_	33	NMOD	_	_
31	similar	_	JJ	_	_	33	NMOD	_	_
32	proliferative	_	JJ	_	_	33	NMOD	_	_
33	lesions	_	NNS	_	_	29	CONJ	_	_
34	.	_	.	_	_	3	P	_	_
		
